Keita Mori
Vermögen: 36 Mio $ am 31.08.2026
Vermögen: 36 Mio $ am 31.08.2026
Keita Mori is the founder of SanBio, Inc., founded in 2001, and holds the title of Chairman since 2018.
Former jobs include Principal at Kirin Brewery Co. Ltd. and Head-New Product Development at Xuma Technologies, Inc. in 2001.
Education history includes an MBA from the University of California, Berkeley, and undergraduate and graduate degrees from the University of Tokyo.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SANBIO CO., LTD. 7.68% | 31.01.2026 | 5’997’284 ( 7.68% ) | 36 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SANBIO COMPANY LIMITED | Vorstandsvorsitzender | 27.02.2013 |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services Develops therapies for neurological disorders | Gründer | 01.02.2001 |
| Unternehmen | Position | Ende |
|---|---|---|
Xuma Technologies, Inc. | Corporate Officer/Principal | 01.01.2001 |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Manufactures beer | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Manufactures beer | Consumer Non-Durables |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services Develops therapies for neurological disorders | Health Services |
Xuma Technologies, Inc. | |
SanBio Co., Ltd.
SanBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and manufacturing of regenerative medicine products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen